TRPV4 and breast carcinoma: The pharmacological activation of TRPV4 promotes cell death via oncosis and apoptosis in breast cancer cells overexpressing TRPV4 [96], and another study found that these channels are required for breast cancer metastasis and transendothelial migration but had no effect on cell growth/proliferation [97].